Valuation (60%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.95 | N/A |
| PEG Ratio (TTM) | -1.77 | N/A |
| P/S Ratio (TTM) | 3.53 | N/A |
| P/B Ratio (TTM) | 1.24 | N/A |
| P/FCF Ratio (TTM) | 12.36 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.02 | N/A |
| Price to 5YR AVG FCF Ratio | 15.98 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.84% | N/A |
| ROE (TTM) | 7.27% | N/A |
| Net Profit Margin (TTM) | 19.65% | N/A |
| ROIC 5YR AVG | 13.31% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.40% | 2.30% | -0.46% |
| Revenue | 2.59% | 5.96% | 15.94% |
| Net Income | -9.22% | 3.00% | 6.70% |
| Cash Flow | 106.49% | 55.05% | 37.64% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.27 | N/A |
| Quick Ratio (TTM) | 0.27 | N/A |
| D/E Ratio (TTM) | 0.01 | N/A |
| Interest Coverage (TTM) | 1.27 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 4.97 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.95% | N/A |